Drug Description in Trials / DrugBank / KEGG DRUG /

Search results

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	指定難病告示番号
1	(-)-Epicatechin	1件: Epicatechin	-	-	-	2件: 86, 113
2	(18F)FPGLU	-	-	-	-	1件: 86
3	(Pyr1)apelin-13	-	-	-	-	1件: 86
4	(S)-2-(4,6-dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid	-	-	-	-	1件: 86
5	(S)-3-((3-(1-((6-(3,4-DIMETHOXYPHENYL)PRYAZIN-2- YL)AMINO)ETHYL)PHENYL)CARBAMOYL)-5-METHYLPRIDIN-1-IUM	-	-	-	-	1件: 86
6	(S)-3-((3-(1-((6-(3,4-DIMETHOXYPHENYL)PRYAZIN-2-YL)AMINO)ETHYL)PHENYL)CARBAMOYL)-5-METHYLPRIDIN-1-IUM	-	-	-	-	1件: 86
7	Comment- IMP inhalation solution identical to ventavis inhalation solution, but IMP is in a different volume presentation. Please see covering letter.	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
8	10-nitro-9(E)-octadec-9-enoic acid	-	-	-	-	1件: 86
9	11C-ACETATE	2件: Acetate, Acetic acid C-11	-	-	-	4件: 6, 13, 86, 88
10	120 mg sodium nitrite inhalation solution	1件: Nitrite	-	-	-	1件: 86
11	129Xe Hyperpolarized	-	-	-	-	1件: 86
12	15 mg sodium nitrite inhalation solution	1件: Nitrite	-	-	-	1件: 86
13	150mg CXA-10	1件: CXA-10	-	-	-	1件: 86
14	171	-	-	-	-	1件: 86
15	2-(4-[5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy)-N-(methylsulfonyl)actamide	-	-	-	-	1件: 86
16	2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl) acetamide	1件: Acetamide	-	-	-	1件: 86
17	20 mg sildenafil citrate by mouth	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
18	20 mg/ml Treprostinil	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
19	25% MTD sodium nitrite inhalation solution	1件: Nitrite	-	-	-	1件: 86
20	400 mg BIA 5-1058	1件: BIA	-	-	-	1件: 86
21	45 mg sodium nitrite inhalation solution	1件: Nitrite	-	-	-	1件: 86
22	4AU76	-	-	-	-	1件: 86
23	66215-101	-	-	-	-	1件: 86
24	6R-BH4	1件: Sapropterin	1件: D08505	-	-	3件: 86, 124, 240
25	75mg CXA-10	1件: CXA-10	-	-	-	1件: 86
26	90 mg sodium nitrite inhalation solution	1件: Nitrite	-	-	-	1件: 86
27	: 2-{4-[(5,6-difenilpirazin-2-yl)(isopropil)amino]butoxi}-N-	-	-	-	-	1件: 86
28	[11C]-GSK2256098 500 MBq	1件: GSK2256098	-	-	-	1件: 86
29	[18F] FES	-	-	-	-	1件: 86
30	[18F]Fluoro-2-deoxy-2-D-glucose	1件: D-glucose	1件: D00009	-	-	2件: 86, 88
31	Access program - sildenafil citrate, Viagra, Revatio	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
32	ACE-011	-	-	-	-	1件: 86
33	ACE-011 / MK - 7962	-	-	-	-	1件: 86
34	ACE-011 / MK-7962	-	-	-	-	1件: 86
35	ACE-011/ MK-7962	-	-	-	-	1件: 86
36	Acetamide	1件: Acetamide	-	-	-	2件: 86, 154
37	Acetaminophen	1件: Acetaminophen	1件: D00217	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬	13件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337
38	Acetate	1件: Acetate	-	-	-	41件: 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299
39	ACT - 064992	-	-	-	-	1件: 86
40	ACT-050089	-	-	-	-	1件: 86
41	ACT-050089 (Ro 61-0612)	-	-	-	-	1件: 86
42	ACT-064992	-	-	-	-	5件: 51, 85, 86, 88, 210
43	ACT-064992 / JNJ-67896062	-	-	-	-	1件: 86
44	ACT-064992/ JNJ-67896062	-	-	-	-	1件: 86
45	ACT-064992D	-	-	-	-	1件: 86
46	ACT-178418	-	-	-	-	1件: 86
47	ACT-293987	-	-	-	-	3件: 51, 86, 88
48	ACT-293987 (NS-304)	-	-	-	-	1件: 86
49	ACT-385781A	-	-	-	-	1件: 86
50	ACT-385781A (Actelion Epoprostenol)	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
51	ActRIIA-IgG1Fc	-	-	-	-	1件: 86
52	Adcirca	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
53	ADCIRCA 20 mg film-coated tablets	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
54	Adcirca®	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
55	Adempas	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	5件: 51, 86, 88, 225, 299
56	Adempas (Riociguat, BAY63-2521)	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	2件: 86, 88
57	ADEMPAS - 0,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
58	ADEMPAS - 1 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	2件: 51, 86
59	ADEMPAS - 1,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	2件: 51, 86
60	ADEMPAS - 2 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	2件: 51, 86
61	ADEMPAS - 2,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	2件: 51, 86
62	Adempas 0.5 mg	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	2件: 86, 299
63	Adempas 0.5 mg Film Coated Tablet	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
64	Adempas 1 mg Film Coated Tablet	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
65	Adempas 1.0 mg	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	2件: 86, 299
66	Adempas 1.5 mg	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
67	Adempas 1.5 mg Film Coated Tablet	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
68	Adempas 2 mg Film Coated Tablet	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
69	Adempas 2.0 mg	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	2件: 86, 299
70	Adempas 2.5 mg	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
71	Adempas 2.5 mg Film Coated Tablet	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
72	Adempas®	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	2件: 86, 88
73	Adempas® 0.5 mg film-coated tablets	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
74	Adempas® 1.0 mg film-coated tablets	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
75	Adempas® 1.5 mg film-coated tablets	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
76	Adempas® 2.0 mg film-coated tablets	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
77	Adempas® 2.5 mg film-coated tablets	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
78	Adempas¿ 0.5 mg compressa rivestita con film	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
79	Adempas¿ 1.0	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
80	Adempas¿ 1.5 mg	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
81	Adempas¿ 2.0 mg	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
82	Adempas¿ 2.5 mg	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
83	Adipose derived mesenchymal stem cells	-	-	-	-	1件: 86
84	AER-901 Solution for Nebulization	-	-	-	-	1件: 86
85	Aerosolized iloprost	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
86	AIR001	-	-	-	-	1件: 86
87	AIR001 (sodium nitrite inhalation solution)	1件: Nitrite	-	-	-	1件: 86
88	AIR001 Inhalation Solution	-	-	-	-	1件: 86
89	AIR001 Inhalation Solution (Expansion arm)	-	-	-	-	1件: 86
90	AL	-	-	-	-	11件: 5, 6, 7, 13, 28, 51, 67, 86, 97, 114, 127
91	Albuterol	1件: Salbutamol	1件: D02147	1件: ADRB2 💬	9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	7件: 12, 13, 86, 89, 113, 256, 299
92	Albuterol.	1件: Salbutamol	1件: D02147	1件: ADRB2 💬	9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
93	Allogeneic Human Cardiosphere-Derived Stem Cells	-	-	-	-	1件: 86
94	Ambrisentan	1件: Ambrisentan	1件: D07077	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	7件: 51, 84, 85, 86, 88, 210, 211
95	Ambrisentan - high dose	1件: Ambrisentan	1件: D07077	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
96	Ambrisentan - low dose	1件: Ambrisentan	1件: D07077	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
97	Ambrisentan 5 mg film-coated tablets	1件: Ambrisentan	1件: D07077	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
98	Ambrisentan 5mg film-coated tablets [marketed product]	1件: Ambrisentan	1件: D07077	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
99	Ambrisentan plus Spironolactone	2件: Ambrisentan, Spironolactone	2件: D00443 , D07077	2件: EDNRA, NR3C2 💬	8件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
100	Ambrisentan Tablet	1件: Ambrisentan	1件: D07077	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
101	AMN107	-	-	-	-	2件: 34, 86
102	Anakinra	1件: Anakinra	1件: D02934	2件: IL1R1, IL1R2 💬	15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬	16件: 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299
103	ANASTROZOLE	1件: Anastrozole	1件: D00960	1件: CYP19A1 💬	3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬	3件: 78, 86, 193
104	Angiotensin	1件: Angiotensin II	2件: D00150 , D02014	2件: AGTR1, AGTR2 💬	16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	7件: 17, 19, 46, 66, 86, 222, 224
105	Apabetalone	1件: Apabetalone	1件: D11131	4件: BRD2, BRD3, BRD4, BRDT 💬	-	1件: 86
106	APD811	-	-	-	-	1件: 86
107	Apelin	-	-	-	-	1件: 86
108	AR392830	-	-	-	-	1件: 86
109	Aspirin	1件: Acetylsalicylic acid	1件: D00109	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬	12件: 13, 22, 46, 49, 51, 58, 64, 86, 113, 158, 210, 231
110	Assigned pulmonary hypertension medication	-	-	-	-	1件: 86
111	Autologous EPCs transfected	-	-	-	-	1件: 86
112	Autologous EPCs transfected with human eNOS	-	-	-	-	1件: 86
113	AV-101	1件: AV-101	-	-	-	2件: 6, 86
114	Aviptadil	1件: Aviptadil	1件: D12127	-	-	5件: 49, 51, 84, 85, 86
115	AZD4831	-	-	-	-	1件: 86
116	Background PAH Therapy	-	-	-	-	1件: 86
117	Bardoxolone	1件: Bardoxolone	1件: D09584	-	-	7件: 66, 67, 84, 85, 86, 218, 222
118	Bardoxolone methyl	2件: Bardoxolone, Bardoxolone methyl	2件: D09584 , D09585	-	-	7件: 66, 67, 84, 85, 86, 218, 222
119	Bardoxolone methyl capsules	2件: Bardoxolone, Bardoxolone methyl	2件: D09584 , D09585	-	-	4件: 66, 67, 86, 222
120	BARDOXOLONE METHYL, CDDO-Me, CDDO-Methyl Ester, NSC 713200, Chemical Name: Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester	2件: Bardoxolone, Bardoxolone methyl	2件: D09584 , D09585	-	-	1件: 86
121	BAY 63-2521	-	-	-	-	2件: 86, 88
122	BAY 63-2521 0.06 %	-	-	-	-	1件: 86
123	BAY 63-2521 0.3 %	-	-	-	-	1件: 86
124	BAY 63-2521 coated tablets 0.5 mg	-	-	-	-	2件: 86, 88
125	BAY 63-2521 coated tablets 1 mg	-	-	-	-	2件: 86, 88
126	BAY 63-2521 coated tablets 1.5 mg	-	-	-	-	2件: 86, 88
127	BAY 63-2521 coated tablets 2 mg	-	-	-	-	2件: 86, 88
128	BAY 63-2521 coated tablets 2.5 mg	-	-	-	-	2件: 86, 88
129	BAY 63-2521 IR tablets 0.5 mg	-	-	-	-	1件: 86
130	BAY 63-2521 IR tablets 1 mg	-	-	-	-	1件: 86
131	BAY 63-2521 IR tablets 1.0 mg	-	-	-	-	1件: 86
132	BAY 63-2521 IR tablets 1.5 mg	-	-	-	-	1件: 86
133	BAY 63-2521 IR tablets 2.0 mg	-	-	-	-	1件: 86
134	BAY 63-2521 IR tablets 2.5 mg	-	-	-	-	1件: 86
135	BAY 63-2521 Tablet	-	-	-	-	1件: 86
136	BAY 63-2521 tablets 0.5 mg	-	-	-	-	2件: 86, 88
137	BAY 63-2521 tablets 1 mg	-	-	-	-	2件: 86, 88
138	BAY 63-2521 tablets 1.5 mg	-	-	-	-	2件: 86, 88
139	BAY 63-2521 tablets 2 mg	-	-	-	-	2件: 86, 88
140	BAY 63-2521 tablets 2.5 mg	-	-	-	-	2件: 86, 88
141	Bay Q 6256	-	-	-	-	1件: 86
142	BAY1237592	-	-	-	-	2件: 86, 88
143	BAY63-2521	-	-	-	-	3件: 51, 86, 299
144	Beetroot juice	-	-	-	-	2件: 67, 86
145	Benzbromaron	-	-	-	-	1件: 86
146	Benzbromaron AL	-	-	-	-	1件: 86
147	BENZBROMARONE	1件: Benzbromarone	1件: D01056	1件: SLC22A12 💬	-	1件: 86
148	Beraprost	1件: Beraprost	1件: D02720	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
149	Beraprost Sodium	1件: Beraprost	1件: D02720	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
150	Beraprost Sodium 314d Modified Release Tablets	1件: Beraprost	1件: D02720	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
151	Beraprost Sodium Modified Release	1件: Beraprost	1件: D02720	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
152	BH4	-	-	-	-	5件: 51, 86, 124, 240, 299
153	BIA	1件: BIA	-	-	-	2件: 6, 86
154	BIA 5-1058	1件: BIA	-	-	-	1件: 86
155	BIA-5-1058	1件: BIA	-	-	-	1件: 86
156	Biological DMARDs	-	-	-	-	2件: 86, 107
157	BISOPROLOL	1件: Bisoprolol	1件: D02342	1件: ADRB1 💬	11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	4件: 58, 67, 86, 113
158	Bosentan	1件: Bosentan	2件: D01227 , D07538	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	10件: 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
159	Bosentan administration	1件: Bosentan	2件: D01227 , D07538	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
160	Bosentan and Sildenafil	2件: Bosentan, Sildenafil	3件: D01227 , D07538 , D08514	3件: EDNRA, EDNRB, PDE5A 💬	11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
161	BOSENTAN MONOHIDRATO	1件: Bosentan	2件: D01227 , D07538	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
162	Bosentan monohydrat	1件: Bosentan	2件: D01227 , D07538	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
163	BOSENTAN MONOHYDRATE	1件: Bosentan	2件: D01227 , D07538	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	4件: 51, 84, 86, 88
164	Bosentan, Ambrisentan	2件: Ambrisentan, Bosentan	3件: D01227 , D07077 , D07538	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
165	BPS-314d-MR	-	-	-	-	1件: 86
166	BPS-MR	-	-	-	-	1件: 86
167	Bromure d'Ipratropium	1件: Ipratropium	-	-	-	1件: 86
168	BSF 208075	-	-	-	-	1件: 86
169	BSF 208075 or LU 208075	-	-	-	-	1件: 86
170	C07AB07	-	-	-	-	1件: 86
171	C225	-	-	-	-	2件: 51, 86
172	Capsaicin	1件: Capsaicin	1件: D00250	1件: TRPV1 💬	2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬	3件: 6, 86, 226
173	Captopril	1件: Captopril	1件: D00251	1件: ACE 💬	6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬	2件: 17, 86
174	Carbon	1件: Activated charcoal	-	-	-	6件: 6, 85, 86, 96, 97, 158
175	Carbon monoxide	2件: Activated charcoal, Carbon monoxide	1件: D09706	-	-	2件: 85, 86
176	Carnitine	1件: Levocarnitine	1件: D02176	-	-	9件: 5, 13, 58, 86, 96, 97, 265, 298, 316
177	Carvedilol	1件: Carvedilol	1件: D00255	5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬	13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	4件: 57, 86, 113, 210
178	Cetuximab	1件: Cetuximab	1件: D03455	1件: EGFR 💬	48件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬	2件: 51, 86
179	Chlorhexidine	1件: Chlorhexidine	1件: D07668	-	-	2件: 86, 299
180	Cialis	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	2件: 51, 86
181	Cialis 10 mg film-coated tablets	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	2件: 86, 113
182	Cialis 2.5 mg film-coated tablets	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	2件: 86, 113
183	CIALIS 20 mg comprimidos recubiertos con película	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
184	Cialis 20 mg film-coated tablets	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	2件: 86, 113
185	Cialis 5 mg film-coated tablets	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	2件: 86, 113
186	Cicletanine	1件: Cicletanine	1件: D03487	-	-	1件: 86
187	Cicletanine hydrochloride	1件: Cicletanine	1件: D03487	-	-	1件: 86
188	Citrulline	1件: Citrulline	-	-	-	2件: 86, 113
189	CJNJ-68150420-ZZZ-G001 (ACT- 064992D)	-	-	-	-	1件: 86
190	CJNJ-68150420-ZZZ-G001 (ACT-064992D)	-	-	-	-	1件: 86
191	CJNJ-68150420-ZZZ-G001(ACT-064992D)	-	-	-	-	1件: 86
192	Clopidogrel	1件: Clopidogrel	3件: D07729 , D10823 , D10824	1件: P2RY12 💬	1件: Platelet activation 💬	3件: 49, 51, 86
193	Coenzyme Q-10	1件: Ubidecarenone	1件: D01065	-	-	1件: 86
194	Coenzyme Q-10 in Normal Control subjects	1件: Ubidecarenone	1件: D01065	-	-	1件: 86
195	Coenzyme Q-10 in Pulmonary Hypertension subjects	1件: Ubidecarenone	1件: D01065	-	-	1件: 86
196	Combination Product:	-	-	-	-	1件: 86
197	Combination Product: Implantable System for Remodulin (treprostinil)	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
198	Combination Product: Treprostinil via implanted pump	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
199	Commercial Ventavis® (iloprost)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
200	Conivaptan	1件: Conivaptan	1件: D07748	2件: AVPR1A, AVPR2 💬	5件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬	1件: 86
201	Conventional drug therapy(expectorant,bronchodilator)	-	-	-	-	1件: 86
202	CosmoFer	-	-	-	-	3件: 86, 96, 97
203	CS1 Administration	-	-	-	-	1件: 86
204	Current marketed FLOLAN (epoprostenol sodium)	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
205	CXA-10	1件: CXA-10	-	-	-	2件: 86, 222
206	D-glucose	1件: D-glucose	1件: D00009	-	-	3件: 49, 86, 88
207	D.3.6.2 - dose massima specificare: giornaliera	-	-	-	-	1件: 86
208	Dapagliflozin	1件: Dapagliflozin	1件: D08897	1件: SLC5A2 💬	-	7件: 19, 49, 66, 67, 86, 88, 222
209	Dapagliflozin 10 MG [Farxiga]	1件: Dapagliflozin	1件: D08897	1件: SLC5A2 💬	-	2件: 86, 88
210	DHEA	1件: Prasterone	1件: D08409	3件: AR, ESR1, ESR2 💬	12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬	3件: 49, 86, 96
211	DHEA tablet	1件: Prasterone	1件: D08409	3件: AR, ESR1, ESR2 💬	12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬	1件: 86
212	Dichloroacetate	1件: Dichloroacetic acid	-	-	-	1件: 86
213	Dichloroacetate Sodium	2件: Dichloroacetic acid, Sodium dichloroacetate	1件: D05857	3件: PDK2, PDK3, PDK4 💬	1件: Diabetic cardiomyopathy 💬	1件: 86
214	Diet	-	-	-	-	4件: 86, 97, 240, 299
215	Dietanolamina de treprostinilo	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
216	Diltiazem	1件: Diltiazem	1件: D07845	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	3件: 51, 58, 86
217	Diltiazem Hydrochloride	1件: Diltiazem	1件: D07845	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
218	DIMETHYL FUMARATE	1件: Dimethyl fumarate	1件: D03846	1件: KEAP1 💬	6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬	4件: 13, 51, 86, 296
219	Dimethyl Fumarate (DMF)	1件: Dimethyl fumarate	1件: D03846	1件: KEAP1 💬	6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬	3件: 13, 51, 86
220	Diphenhydramine	1件: Diphenhydramine	1件: D00300	1件: HRH1 💬	3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬	8件: 11, 13, 49, 51, 70, 86, 222, 256
221	Dobutamine	1件: Dobutamine	1件: D03879	1件: ADRB1 💬	11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	4件: 57, 58, 86, 215
222	Dobutamine test	1件: Dobutamine	1件: D03879	1件: ADRB1 💬	11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
223	Duo-Therapy with Sildenafil + Bosentan	2件: Bosentan, Sildenafil	3件: D01227 , D07538 , D08514	3件: EDNRA, EDNRB, PDE5A 💬	11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
224	EFI/ACT-385781A	-	-	-	-	1件: 86
225	Elafin	1件: Elafin	-	-	-	1件: 86
226	Endothelin receptor antagonist therapy	-	-	-	-	1件: 86
227	Endothelin Receptor Antagonists	-	-	-	-	1件: 86
228	Endothelin-3	-	-	-	-	1件: 86
229	ENOS transfected EPCs will be delivered via a PA line	-	-	-	-	1件: 86
230	Epicatechin	1件: Epicatechin	-	-	-	2件: 86, 113
231	EPOPROSTENOL	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
232	Epoprostenol for injection	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
233	EPOPROSTENOL SODICO	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
234	EPOPROSTENOL SODIUM	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
235	Epoprostenol-Actelion	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
236	Epoprostenolo per iniezione	-	-	-	-	1件: 86
237	Equal	-	-	-	-	4件: 6, 13, 67, 86
238	ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan)	4件: Bosentan, Macitentan, Sildenafil, Tadalafil	5件: D01227 , D02008 , D07538 , D08514 , D10135	3件: EDNRA, EDNRB, PDE5A 💬	11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
239	ERA as specific PAH treatment	-	-	-	-	1件: 86
240	Erbitux	1件: Cetuximab	1件: D03455	1件: EGFR 💬	48件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬	2件: 51, 86
241	Esomeprazole	1件: Esomeprazole	1件: D07917	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬	8件: 13, 46, 86, 98, 107, 113, 298, 299
242	ESR-specific PET scan	-	-	-	-	1件: 86
243	Esuberaprost	-	-	-	-	1件: 86
244	Eutonic Treprostinil Solution	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
245	Famotidine	1件: Famotidine	1件: D00318	1件: HRH2 💬	3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬	5件: 6, 46, 86, 98, 107
246	Famotidine 20 MG	1件: Famotidine	1件: D00318	1件: HRH2 💬	3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬	1件: 86
247	FDC macitentan/tadalafil	2件: Macitentan, Tadalafil	2件: D02008 , D10135	3件: EDNRA, EDNRB, PDE5A 💬	11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
248	Ferinject	-	-	-	-	2件: 86, 299
249	Ferinject or CosmoFer	-	-	-	-	1件: 86
250	FERRIC CARBOXYMALTOSE	1件: Ferric carboxymaltose	1件: D08920	-	-	4件: 86, 96, 97, 299
251	Ferricarboxymaltose	-	-	-	-	1件: 86
252	FK506 level 2-3 ng/ml	-	-	-	-	1件: 86
253	FK506 level 3-5 ng/ml	-	-	-	-	1件: 86
254	FK506 level < 2 ng/ml	-	-	-	-	1件: 86
255	Flolan	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
256	FLOLAN injection with currently marketed diluent	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
257	FLOLAN injection with reformulated diluent	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
258	FLOLAN TM and Glycine Diluent	2件: Epoprostenol, Glycine	2件: D00011 , D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
259	Flolan®	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
260	FLOLAN™ and Glycine Diluent	2件: Epoprostenol, Glycine	2件: D00011 , D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
261	FLUOXETINE	1件: Fluoxetine	1件: D00326	1件: SLC6A4 💬	2件: Serotonergic synapse, Synaptic vesicle cycle 💬	4件: 13, 17, 78, 86
262	Forxiga	1件: Dapagliflozin	1件: D08897	1件: SLC5A2 💬	-	2件: 86, 88
263	Forxiga (dapagliflozin)	1件: Dapagliflozin	1件: D08897	1件: SLC5A2 💬	-	2件: 86, 88
264	Fulvestrant	1件: Fulvestrant	1件: D01161	2件: ESR1, ESR2 💬	10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬	1件: 86
265	Furosemide	1件: Furosemide	1件: D00331	1件: SLC12A2 💬	3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬	2件: 6, 86
266	G04BE03	-	-	-	-	1件: 86
267	G04BE03- Sildenafil - sildenafil (citrato)	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
268	G04BE08	-	-	-	-	1件: 86
269	GB002	-	-	-	-	1件: 86
270	GB002 (seralutinib)	-	-	-	-	1件: 86
271	GB002 Capsules	-	-	-	-	1件: 86
272	GLIVEC	1件: Imatinib	1件: D08066	3件: ABL1, KIT, PDGFRA 💬	32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬	2件: 51, 86
273	GLIVEC 100 mg comprimidos recubiertos con película	1件: Imatinib	1件: D08066	3件: ABL1, KIT, PDGFRA 💬	32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬	2件: 34, 86
274	Glivec 100 mg Filmtabletten	1件: Imatinib	1件: D08066	3件: ABL1, KIT, PDGFRA 💬	32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬	2件: 51, 86
275	Glivec 100 mg Hartkapsel	1件: Imatinib	1件: D08066	3件: ABL1, KIT, PDGFRA 💬	32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬	1件: 86
276	Glivec®	1件: Imatinib	1件: D08066	3件: ABL1, KIT, PDGFRA 💬	32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬	1件: 86
277	Glivec® 100 mg Filmtabletten	1件: Imatinib	1件: D08066	3件: ABL1, KIT, PDGFRA 💬	32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬	1件: 86
278	Glucose	1件: Dextrose, unspecified form	-	-	-	12件: 2, 6, 13, 49, 50, 66, 86, 88, 96, 97, 257, 299
279	GLYCINE	1件: Glycine	1件: D00011	-	-	5件: 35, 60, 86, 226, 299
280	GMA301 Injection	-	-	-	-	1件: 86
281	Gold	1件: Gold	-	-	-	43件: 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318
282	GS-4997 18 mg	-	-	-	-	1件: 86
283	GS-4997 2 mg	-	-	-	-	1件: 86
284	GS-4997 6 mg	-	-	-	-	1件: 86
285	GSK1325760	-	-	-	-	2件: 86, 88
286	GSK1325760A	-	-	-	-	1件: 86
287	GSK2256098	1件: GSK2256098	-	-	-	1件: 86
288	GSK2586881	-	-	-	-	1件: 86
289	HGP1206	-	-	-	-	1件: 86
290	Hydroxyurea	1件: Hydroxyurea	1件: D00341	1件: RRM2 💬	7件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬	8件: 3, 13, 19, 20, 65, 85, 86, 284
291	Hyperpolarized 129Xe	-	-	-	-	1件: 86
292	Hyperpolarized Xe129	-	-	-	-	4件: 51, 85, 86, 299
293	HypotonicTreprostinil Solution	-	-	-	-	1件: 86
294	I.v. selexipag	1件: Selexipag	1件: D09994	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
295	Ilomedin 20	-	-	-	-	1件: 86
296	Ilomedin 20 [20 µg / ml]	-	-	-	-	1件: 86
297	Iloprost	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	4件: 51, 84, 85, 86
298	Iloprost (5 µg)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
299	Iloprost (Ventavis BAYQ6256)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
300	Iloprost (Ventavis inhaled, BAYQ6256)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
301	Iloprost (Ventavis, BAYQ 6256)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
302	Iloprost (Ventavis, BAYQ6256)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
303	Iloprost (Ventavis®)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
304	Iloprost Inhalation Solution (Ventavis)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	2件: 85, 86
305	Iloprost PD-15	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
306	Iloprost PD-6	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
307	Iloprost,(Ventavis, BAYQ6256)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
308	Imatinib	1件: Imatinib	1件: D08066	3件: ABL1, KIT, PDGFRA 💬	32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬	12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
309	IMATINIB MESILATE	1件: Imatinib	1件: D08066	3件: ABL1, KIT, PDGFRA 💬	32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬	3件: 13, 86, 88
310	Imatinib Mesylate	1件: Imatinib	1件: D08066	3件: ABL1, KIT, PDGFRA 💬	32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬	5件: 13, 28, 34, 51, 86
311	Inhaled dry powder treprostinil (LIQ861)	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
312	Inhaled Iloprost (5 µg)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
313	Inhaled iloprost (Ventavis, BAYQ6256)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
314	Inhaled Nitric Oxide	1件: Nitric Oxide	1件: D00074	-	-	2件: 85, 86
315	Inhaled nitric oxide & INOpulse delivery	1件: Nitric Oxide	1件: D00074	-	-	1件: 86
316	Inhaled nitric oxide 75 mcg/kg IBW/hr	1件: Nitric Oxide	1件: D00074	-	-	2件: 85, 86
317	Inhaled NO with pulsed delivery	-	-	-	-	1件: 86
318	Inhaled prostacyclin	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
319	Inhaled Treprostinil	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	3件: 84, 85, 86
320	INO	-	-	-	-	2件: 85, 86
321	Intestinal microbiota transplant (IMT)	-	-	-	-	1件: 86
322	Intravenous administration of ferric carboxymaltose	1件: Ferric carboxymaltose	1件: D08920	-	-	1件: 86
323	Intravenous Treprostinil	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
324	Ipratropium	1件: Ipratropium	-	-	-	2件: 6, 86
325	Iron supplement	-	-	-	-	1件: 86
326	JNJ-67896049	-	-	-	-	1件: 86
327	JNJ-67896049 (ACT-293987)	-	-	-	-	1件: 86
328	JNJ-67896062 / ACT-064992	-	-	-	-	2件: 86, 88
329	JNJ-67896062/ ACT-064992	-	-	-	-	2件: 86, 88
330	JNJ-67896062/ACT-064922	-	-	-	-	1件: 86
331	JTT-251	-	-	-	-	1件: 86
332	KAR5585 Capsules	-	-	-	-	1件: 86
333	L-Carnitine	1件: Levocarnitine	1件: D02176	-	-	7件: 13, 86, 96, 97, 265, 298, 316
334	L-Citrulline Malate	1件: Citrulline	-	-	-	1件: 86
335	L606 (Liposomal Treprostinil) Inhalation Solution 51ug	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
336	Levitra	1件: Vardenafil	1件: D08668	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	2件: 13, 86
337	Lidocaine	1件: Lidocaine	2件: D00358 , D08127	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬	12件: 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 256
338	LIQ861 100 µg	-	-	-	-	1件: 86
339	LIQ861 106 µg	-	-	-	-	1件: 86
340	LIQ861 25 µg	-	-	-	-	1件: 86
341	LIQ861 26.5 µg	-	-	-	-	1件: 86
342	LIQ861 50 µg	-	-	-	-	1件: 86
343	LIQ861 53 µg	-	-	-	-	1件: 86
344	LIQ861 75 µg	-	-	-	-	1件: 86
345	LIQ861 79.5 µg	-	-	-	-	1件: 86
346	LIQ861 Inhaled Treprostinil	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
347	LISURIDE	1件: Lisuride	1件: D08132	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬	2件: 6, 86
348	Lloprost(Ventavis,BAYQ6252, 10 µg/mL)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
349	Lloprost(Ventavis,BAYQ6252, 20 µg/mL)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
350	LTP001	-	-	-	-	2件: 85, 86
351	LY450190	-	-	-	-	1件: 86
352	Macitentan	1件: Macitentan	1件: D10135	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	5件: 51, 85, 86, 88, 210
353	Macitentan (ACT-064992)	1件: Macitentan	1件: D10135	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
354	Macitentan 10 mg	1件: Macitentan	1件: D10135	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	3件: 51, 86, 88
355	Macitentan 10 mg tablet, once daily.	1件: Macitentan	1件: D10135	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
356	Macitentan 37.5 mg	1件: Macitentan	1件: D10135	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
357	Macitentan 75 mg	1件: Macitentan	1件: D10135	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
358	MACITENTAN COMPRESSE	1件: Macitentan	1件: D10135	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	2件: 86, 88
359	Macitentan Group	1件: Macitentan	1件: D10135	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
360	MACITENTAN TABLETS	1件: Macitentan	1件: D10135	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	2件: 86, 88
361	MD-711	-	-	-	-	1件: 86
362	Medical air	2件: Medical air, Oxygen	1件: D00003	-	-	3件: 85, 86, 193
363	Metformin	1件: Metformin	1件: D04966	2件: PRKAA1, PRKAA2 💬	20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬	25件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301
364	Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo	-	-	-	-	1件: 86
365	Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb	-	-	-	-	2件: 86, 88
366	Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth	-	-	-	-	2件: 86, 88
367	Methylprednisolone	1件: Methylprednisolone	1件: D00407	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296
368	MK-4836	-	-	-	-	2件: 86, 88
369	MK-5475	-	-	-	-	1件: 86
370	MK-7962	-	-	-	-	1件: 86
371	MK-8892	-	-	-	-	1件: 86
372	MN-08 24 mg/day	-	-	-	-	1件: 86
373	MN-08 60 mg/day	-	-	-	-	1件: 86
374	Mono-Therapy with Sildenafil	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
375	Morphine	1件: Morphine	1件: D08233	1件: OPRM1 💬	3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬	5件: 36, 46, 70, 85, 86
376	MORPHINE SULFATE	2件: Morphine, Sulfate ion	1件: D08233	1件: OPRM1 💬	3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬	3件: 46, 85, 86
377	Moxifloxacin	1件: Moxifloxacin	1件: D08237	-	-	9件: 2, 6, 46, 49, 85, 86, 113, 240, 299
378	Moxifloxacin 400 mg	1件: Moxifloxacin	1件: D08237	-	-	1件: 86
379	MultiHance	1件: Gadobenic acid	1件: D08018	-	-	2件: 86, 88
380	Nab-sirolimus (also known as ABI-009, nab-rapamycin, albumin-bound rapamycin)	1件: Sirolimus	1件: D00753	1件: MTOR 💬	51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬	1件: 86
381	Nebulized combination ipratropium bromide with salbutamol	2件: Ipratropium, Salbutamol	1件: D02147	1件: ADRB2 💬	9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
382	Nebulized ipratropium bromide	1件: Ipratropium	-	-	-	1件: 86
383	New thermo stable formulation of epoprostenol sodium	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
384	Nicardipine	1件: Nicardipine	1件: D08270	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	2件: 70, 86
385	Nilotinib	1件: Nilotinib	1件: D08953	4件: ABL1, KIT, PDGFRA, PDGFRB 💬	33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬	5件: 6, 8, 34, 51, 86
386	Nilotinib 50 mg	1件: Nilotinib	1件: D08953	4件: ABL1, KIT, PDGFRA, PDGFRB 💬	33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬	1件: 86
387	NITRIC OXIDE	1件: Nitric Oxide	1件: D00074	-	-	7件: 85, 86, 88, 210, 251, 294, 299
388	Nitric Oxide for inhalation	1件: Nitric Oxide	1件: D00074	-	-	2件: 86, 299
389	Nitric Oxide generated by the GeNO nitrosyl delivery system	1件: Nitric Oxide	1件: D00074	-	-	1件: 86
390	Nitric Oxide plus Oxygen	2件: Nitric Oxide, Oxygen	2件: D00003 , D00074	-	-	1件: 86
391	Nitrite	1件: Nitrite	-	-	-	2件: 58, 86
392	Nitrosyl	1件: Nitric Oxide	1件: D00074	-	-	1件: 86
393	NO	-	-	-	-	9件: 6, 46, 58, 62, 86, 97, 222, 299, 321
394	Non-Biologic DMARDs	-	-	-	-	3件: 46, 86, 107
395	NS-304	-	-	-	-	3件: 70, 86, 88
396	Null	-	-	-	-	16件: 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271
397	NX1011	-	-	-	-	1件: 86
398	Observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi	4件: Epoprostenol, Iloprost, Macitentan, Selexipag	4件: D00106 , D02721 , D09994 , D10135	3件: EDNRA, EDNRB, PTGIR 💬	10件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Platelet activation, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
399	Olaparib	1件: Olaparib	1件: D09730	2件: PARP1, PARP2 💬	5件: Apoptosis, Base excision repair, Diabetic cardiomyopathy, NF-kappa B signaling pathway, Necroptosis 💬	2件: 86, 285
400	Opsumit	1件: Macitentan	1件: D10135	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	3件: 86, 88, 210
401	Opsumit (macitentan)	1件: Macitentan	1件: D10135	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
402	Opsumit®	1件: Macitentan	1件: D10135	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	3件: 86, 88, 210
403	Oral anticoagulant treatment	-	-	-	-	1件: 86
404	Oral ERA	-	-	-	-	1件: 86
405	Oral PDE5 inhibitors	-	-	-	-	1件: 86
406	Oral selexipag (Uptravi)	1件: Selexipag	1件: D09994	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
407	Oral sildenafil	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
408	Oral treprostinil	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	2件: 51, 86
409	Oral treprostinil (UT-15C) Sustained Release Tablets	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
410	Ossido Nitrico	-	-	-	-	1件: 86
411	Oxygen	1件: Oxygen	1件: D00003	-	-	13件: 6, 49, 70, 85, 86, 88, 90, 96, 168, 193, 271, 299, 330
412	Oxygen supplementation	1件: Oxygen	1件: D00003	-	-	1件: 86
413	Oxygen, liquid	1件: Oxygen	1件: D00003	-	-	2件: 86, 88
414	PAH	-	-	-	-	3件: 49, 53, 86
415	PAH medication	-	-	-	-	1件: 86
416	PAH Therapies	-	-	-	-	1件: 86
417	Parenteral Remodulin (treprostinil) injection	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
418	Parenteral Treprostinil	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
419	PB1046	-	-	-	-	1件: 86
420	PB1046 Subcutaneous Injection	-	-	-	-	1件: 86
421	PB1046, VIP-ELP1-120, Vasomera	-	-	-	-	1件: 86
422	PDE5 inhibitor	-	-	-	-	1件: 86
423	Pemziviptadil (PB1046) Injection	-	-	-	-	1件: 86
424	Pentoxifylline	1件: Pentoxifylline	1件: D00501	-	-	12件: 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298
425	PF-00489791	1件: PF-00489791	-	-	-	1件: 86
426	Pioglitazone	1件: Pioglitazone	1件: D08378	1件: PPARG 💬	11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬	17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
427	Placebo	-	-	-	-	28件: 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276
428	PLX-PAD	1件: Placental Mesenchymal Stem Cells	-	-	-	1件: 86
429	Prednisone	1件: Prednisone	1件: D00473	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction 💬	45件: 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331
430	Prostacyclin	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
431	Prostacyclin Receptor Agonist	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
432	Puri-Nethol	-	-	-	-	3件: 86, 96, 97
433	Q4W GMA301 IV injections (1000 mg)	-	-	-	-	1件: 86
434	Q4W GMA301 IV injections (300 mg)	-	-	-	-	1件: 86
435	Q4W GMA301 IV injections (600 mg)	-	-	-	-	1件: 86
436	QCC374	-	-	-	-	1件: 86
437	QCC374 0.015 mg	-	-	-	-	1件: 86
438	QCC374 0.06 mg	-	-	-	-	1件: 86
439	QTI571	-	-	-	-	1件: 86
440	Qutenza	-	-	-	-	1件: 86
441	Qutenza (8% capsaicin)	1件: Capsaicin	1件: D00250	1件: TRPV1 💬	2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬	1件: 86
442	RALINEPAG	1件: Ralinepag	1件: D10725	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
443	Ranolazine	1件: Ranolazine	1件: D05700	-	-	6件: 2, 58, 86, 96, 113, 114
444	Rapamycin	1件: Sirolimus	1件: D00753	1件: MTOR 💬	51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬	18件: 15, 34, 35, 46, 49, 51, 53, 60, 61, 67, 86, 89, 96, 157, 158, 193, 256, 279
445	Rapid Dose Titration Group of Subcutaneous Treprostinil	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
446	Recombinant Human Angiotensin-Converting Enzyme 2	2件: Alunacedase alfa, Angiotensin II	2件: D00150 , D02014	2件: AGTR1, AGTR2 💬	16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
447	Recombinant Human Angiotensin-converting enzyme 2 (ACE2), APN01	2件: Alunacedase alfa, Angiotensin II	2件: D00150 , D02014	2件: AGTR1, AGTR2 💬	16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
448	Remodulin	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	2件: 86, 88
449	Remodulin (treprostinil sodium)	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
450	Remodulin® (treprostinil) 1 mg/ml solution for infusion	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
451	Remodulin® (treprostinil) 10 mg/ml solution for infusion	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
452	Remodulin® (treprostinil) 2.5 mg/ml solution for infusion	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
453	Remodulin® (treprostinil) 5 mg/ml solution for infusion	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
454	Revatio	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	3件: 85, 86, 113
455	Revatio 10 mg/ml powder for oral suspension	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
456	Revatio 20 mg film coated tablets	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
457	Revatio 20 mg film-coated tablets	-	-	-	-	1件: 86
458	Revatio 20 mg Filmtabletten	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
459	REVATIO 20 mg, comprimidos recubiertos con película	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
460	Revatio inyectable	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
461	Revatio oral	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
462	Revatio POS	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
463	Revatio Tablets	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
464	Revatio ® 20 mg film-coated tablets	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
465	Revatio®	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
466	Riciguat Group	-	-	-	-	1件: 86
467	Rifampin	1件: Rifampicin	1件: D00211	-	-	5件: 6, 13, 84, 86, 299
468	RIOCIGUAT	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	6件: 51, 84, 86, 88, 225, 299
469	Riociguat (Adempas, BAY63-2521)	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	4件: 51, 86, 88, 299
470	Riociguat (BAY63-2521)	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
471	Riociguat granules 0.3% for oral application	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
472	Riociguat Oral Product	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
473	Riociguat Oral Tablet	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	3件: 51, 86, 88
474	Riociguat Pill	1件: Riociguat	1件: D09572	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬	1件: 86
475	Ritonavir	1件: Ritonavir	1件: D00427	-	-	3件: 2, 86, 265
476	RITUXIMAB	1件: Rituximab	1件: D02994	1件: MS4A1 💬	1件: Hematopoietic cell lineage 💬	48件: 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
477	Ro 47-0203	-	-	-	-	4件: 51, 85, 86, 88
478	Ro 47-0203 / ACT-050088	-	-	-	-	1件: 86
479	Ro-47-0203	-	-	-	-	1件: 86
480	Ro-47-0203/029	-	-	-	-	1件: 86
481	Ro47-0203	-	-	-	-	1件: 86
482	Ro47-0203 / ACT-050088	-	-	-	-	2件: 51, 86
483	RoActemra	1件: Tocilizumab	1件: D02596	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬	11件: 40, 41, 44, 46, 50, 51, 86, 107, 266, 271, 331
484	Rodatristat ethyl	-	-	-	-	1件: 86
485	Rodatristat ethyl 300 mg tablet BID	-	-	-	-	1件: 86
486	Rodatristat ethyl 600 mg BID	-	-	-	-	1件: 86
487	RT234 - vardenafil inhalation powder	1件: Vardenafil	1件: D08668	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
488	RTA 402	-	-	-	-	3件: 67, 86, 218
489	RVG 33865	-	-	-	-	1件: 86
490	RVT-1201	-	-	-	-	1件: 86
491	Salbutamol	1件: Salbutamol	1件: D02147	1件: ADRB2 💬	9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	8件: 3, 11, 49, 85, 86, 111, 256, 299
492	Saline	-	-	-	-	10件: 6, 13, 17, 53, 67, 78, 86, 97, 168, 299
493	Sapropterin	1件: Sapropterin	1件: D08505	-	-	3件: 86, 124, 240
494	Sapropterin dihydrochloride (6R-BH4)	1件: Sapropterin	1件: D08505	-	-	1件: 86
495	Saquinavir	1件: Saquinavir	1件: D00429	-	-	2件: 86, 265
496	Saquinavir and ritonavir	2件: Ritonavir, Saquinavir	2件: D00427 , D00429	-	-	1件: 86
497	SATRALIZUMAB	1件: Satralizumab	1件: D11079	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬	3件: 11, 13, 86
498	Satralizumab (Genetical Recombination)	1件: Satralizumab	1件: D11079	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬	1件: 86
499	Sauerstoff	-	-	-	-	2件: 86, 88
500	SELEXIPAG	1件: Selexipag	1件: D09994	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	5件: 51, 70, 84, 86, 88
501	Selexipag (Uptravi)	1件: Selexipag	1件: D09994	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
502	Selexipag, ACT-293987 (NS-304)	1件: Selexipag	1件: D09994	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
503	Selonsertib	1件: Selonsertib	1件: D10988	1件: MAP3K5 💬	20件: Alcoholic liver disease, Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Huntington disease, Lipid and atherosclerosis, MAPK signaling pathway, Neurotrophin signaling pathway, Non-alcoholic fatty liver disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Protein processing in endoplasmic reticulum, Sphingolipid signaling pathway, Spinocerebellar ataxia, TNF signaling pathway, Thermogenesis, Tight junction 💬	1件: 86
504	Seralutinib	-	-	-	-	1件: 86
505	Serine	1件: Serine	1件: D00016	-	-	4件: 2, 6, 86, 96
506	Sham O2 (medical air)	2件: Medical air, Oxygen	1件: D00003	-	-	1件: 86
507	SILDENAF	-	-	-	-	1件: 86
508	Sildenafil	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301
509	Sildenafil (as citrate)	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
510	Sildenafil (REVATIO)	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
511	Sildenafil (Revatio) 20 mg TID	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
512	Sildenafil 20mg	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	2件: 51, 86
513	Sildenafil 20mg and Bosentan 62.5mg	2件: Bosentan, Sildenafil	3件: D01227 , D07538 , D08514	3件: EDNRA, EDNRB, PDE5A 💬	11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	2件: 51, 86
514	Sildenafil citrate	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	4件: 51, 85, 86, 225
515	Sildenafil citrate (UK-92,480)	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
516	Sildenafil Filmtabletten	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
517	Sildenafil singly or in association with Bosentan	2件: Bosentan, Sildenafil	3件: D01227 , D07538 , D08514	3件: EDNRA, EDNRB, PDE5A 💬	11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
518	SILDENAFILO	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
519	Simvastatin	1件: Simvastatin	1件: D00434	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬	21件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310
520	Simvastatin 40 mg	1件: Simvastatin	1件: D00434	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬	1件: 86
521	Simvastatin 40 mg tablets	1件: Simvastatin	1件: D00434	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬	1件: 86
522	Sirolimus	1件: Sirolimus	1件: D00753	1件: MTOR 💬	51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬	35件: 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 98, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 300, 331
523	Sitaxentan	1件: Sitaxentan	1件: D07171	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
524	Sitaxentan sodium	1件: Sitaxentan	1件: D07171	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
525	Sitaxsentan	1件: Sitaxentan	1件: D07171	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
526	Sitaxsentan alone	1件: Sitaxentan	1件: D07171	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
527	Sitaxsentan and Sildenafil	2件: Sildenafil, Sitaxentan	2件: D07171 , D08514	2件: EDNRA, PDE5A 💬	9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
528	SITAXSENTAN SODIUM	1件: Sitaxentan	1件: D07171	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
529	Slow Dose Titration Group of Subcutaneous Treprostinil	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
530	SODIUM NITRITE	1件: Nitrite	-	-	-	1件: 86
531	Sodium Nitrite Inhalation Solution	1件: Nitrite	-	-	-	1件: 86
532	Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth	2件: Dextrose, unspecified form, Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
533	Sorafenib	1件: Sorafenib	1件: D08524	8件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬	89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬	2件: 34, 86
534	SOTATERCEPT	1件: Sotatercept	1件: D09670	1件: ACVR2A 💬	4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬	2件: 86, 284
535	Sotatercept - 45 mg/vial	1件: Sotatercept	1件: D09670	1件: ACVR2A 💬	4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬	1件: 86
536	Sotatercept - 60 mg/vial	1件: Sotatercept	1件: D09670	1件: ACVR2A 💬	4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬	1件: 86
537	Spironolactone	1件: Spironolactone	1件: D00443	1件: NR3C2 💬	1件: Aldosterone-regulated sodium reabsorption 💬	8件: 46, 58, 67, 86, 113, 210, 218, 225
538	Spironolactone and conivaptan	2件: Conivaptan, Spironolactone	2件: D00443 , D07748	3件: AVPR1A, AVPR2, NR3C2 💬	6件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬	1件: 86
539	Spironolactone captopril carvedilol	3件: Captopril, Carvedilol, Spironolactone	3件: D00251 , D00255 , D00443	7件: ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬	19件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
540	STI571	-	-	-	-	2件: 51, 86
541	Subcutaneous and intravenous prostacyclin	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
542	Subcutaneous Treprostinil	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
543	Sugar pill	-	-	-	-	8件: 5, 6, 49, 67, 70, 86, 206, 210
544	SULFASALAZINE	1件: Sulfasalazine	1件: D00448	-	-	6件: 46, 86, 94, 107, 270, 271
545	Sulfate	1件: Sulfate ion	-	-	-	27件: 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299
546	Tadalafil	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	7件: 6, 51, 75, 84, 86, 113, 210
547	Tadalafil 20 mg film-coated tablets	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
548	Tadalafil 40 mg	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
549	Tadalafil and ambrisentan upfront combination therapy	2件: Ambrisentan, Tadalafil	2件: D02008 , D07077	2件: EDNRA, PDE5A 💬	9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	2件: 51, 86
550	Tadalafil oral suspension	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
551	Tadalafil- Tablet or Oral suspension	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
552	TADALAFILO	1件: Tadalafil	1件: D02008	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	1件: 86
553	Tasigna	1件: Nilotinib	1件: D08953	4件: ABL1, KIT, PDGFRA, PDGFRB 💬	33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬	2件: 34, 86
554	Tasigna®	1件: Nilotinib	1件: D08953	4件: ABL1, KIT, PDGFRA, PDGFRB 💬	33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬	1件: 86
555	Tasigna® 150 mg	1件: Nilotinib	1件: D08953	4件: ABL1, KIT, PDGFRA, PDGFRB 💬	33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬	1件: 86
556	TBD	-	-	-	-	5件: 19, 86, 90, 276, 299
557	Tegaderm	-	-	-	-	1件: 86
558	Terguride	1件: Terguride	1件: D01348	2件: DRD2, PRL 💬	12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬	2件: 51, 86
559	Terguride 0,5mg tablet	1件: Terguride	1件: D01348	2件: DRD2, PRL 💬	12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬	1件: 86
560	Terguride 0.5 mg tablet	1件: Terguride	1件: D01348	2件: DRD2, PRL 💬	12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬	1件: 86
561	Tezosentan	1件: Tezosentan	-	-	-	1件: 86
562	The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:	-	-	-	-	1件: 86
563	The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:	-	-	-	-	1件: 86
564	Thelin	1件: Sitaxentan	1件: D07171	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
565	Threonine	1件: Threonine	1件: D00041	-	-	2件: 86, 97
566	Tocilizumab	1件: Tocilizumab	1件: D02596	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬	21件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331
567	TOLVAPTAN	1件: Tolvaptan	1件: D01213	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬	4件: 67, 72, 86, 225
568	TPN171H	-	-	-	-	1件: 86
569	TPN171H single dose	-	-	-	-	1件: 86
570	Traclear	-	-	-	-	1件: 86
571	Tracleer	1件: Bosentan	2件: D01227 , D07538	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	8件: 13, 51, 84, 85, 86, 88, 210, 211
572	TRACLEER 62,5 mg comprimidos recubiertos con película	1件: Bosentan	2件: D01227 , D07538	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
573	TRACLEER 62,5MG 56CPR RIV.	1件: Bosentan	2件: D01227 , D07538	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
574	TRACLEER*125MG 56CPR RIV.	1件: Bosentan	2件: D01227 , D07538	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	2件: 51, 86
575	TRACLEER*56CPR RIV 125MG	1件: Bosentan	2件: D01227 , D07538	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	3件: 51, 86, 88
576	Tracleer®	-	-	-	-	1件: 86
577	Transdihydrolisuride	-	-	-	-	2件: 51, 86
578	TRE	-	-	-	-	1件: 86
579	Treprosinil Diethanolamine	-	-	-	-	1件: 86
580	Treprostin	-	-	-	-	1件: 86
581	Treprostinil	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	6件: 51, 84, 85, 86, 88, 210
582	Treprostinil dietanolamina	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
583	Treprostinil diethanolamine	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	2件: 51, 86
584	Treprostinil Diolamine	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
585	Treprostinil Inhalation Powder	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
586	Treprostinil inhalations	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
587	Treprostinil Injectable Product	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
588	Treprostinil Palmitil	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
589	TREPROSTINIL SODIUM	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	3件: 51, 86, 88
590	Treprostinil Sodium Solution for Inhalation	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
591	TREPROSTINIL SODIUM, UT-15	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
592	Treprostinil, UT-15, LRX-15, 15AU81, BW A15AU, U-62, 840	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
593	Treprostinilo	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
594	Trimetazidine	1件: Trimetazidine	1件: D08642	-	-	3件: 2, 58, 86
595	Trisuva(r)	-	-	-	-	1件: 86
596	TRK-100STP	-	-	-	-	1件: 86
597	Tyrosine	1件: Tyrosine	1件: D00022	-	-	3件: 6, 86, 111
598	Tyvaso	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
599	Tyvaso Inhalation Solution	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
600	Ubenimex	1件: Ubenimex	1件: D00087	1件: ANPEP 💬	4件: Glutathione metabolism, Hematopoietic cell lineage, Metabolic pathways, Renin-angiotensin system 💬	1件: 86
601	Udenafil	1件: Udenafil	1件: D10027	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	2件: 86, 210
602	UK 092480	-	-	-	-	1件: 86
603	UK-92,480	-	-	-	-	1件: 86
604	UK-92,480-10	-	-	-	-	1件: 86
605	ULARITIDE	1件: Ularitide	-	-	-	1件: 86
606	Uptravi	1件: Selexipag	1件: D09994	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	3件: 84, 86, 88
607	Urodilatin	-	-	-	-	1件: 86
608	UT-15C	-	-	-	-	1件: 86
609	UT-15C (treprostinil diethanolamine)	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
610	UT-15C 0.25 mg	-	-	-	-	1件: 86
611	UT-15C 1 mg	-	-	-	-	1件: 86
612	UT-15C 5 mg	-	-	-	-	1件: 86
613	UT-15C LP	-	-	-	-	1件: 86
614	UT-15C SR	-	-	-	-	2件: 51, 86
615	UT-15C SR (treprostinil diethanolamine)	1件: Treprostinil	1件: D06213	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
616	UT-15C-SR	-	-	-	-	2件: 51, 86
617	Vardenafil	1件: Vardenafil	1件: D08668	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	3件: 13, 86, 299
618	Vasomera (PB1046) Injection	-	-	-	-	1件: 86
619	Veletri	1件: Epoprostenol	1件: D00106	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
620	Ventavis	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
621	Ventavis (Iloprost, BAYQ6256)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
622	Ventavis 10	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
623	Ventavis(Iloprost)	1件: Iloprost	1件: D02721	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬	1件: 86
624	VIAGRA	1件: Sildenafil	1件: D08514	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬	3件: 86, 96, 225
625	VIP	-	-	-	-	3件: 49, 51, 86
626	Volibris	1件: Ambrisentan	1件: D07077	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	4件: 51, 85, 86, 88
627	VOLIBRIS 10 mg comprimidos recubiertos con película	1件: Ambrisentan	1件: D07077	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
628	VOLIBRIS 5 mg comprimidos recubiertos con película	1件: Ambrisentan	1件: D07077	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
629	VOLIBRIS® (ambrisentan)	1件: Ambrisentan	1件: D07077	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
630	VOLIBRIS™ tablets	1件: Ambrisentan	1件: D07077	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬	1件: 86
631	Warfarin	1件: Warfarin	1件: D08682	2件: NQO1, VKORC1 💬	7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬	11件: 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91
632	ZAMICASTAT	1件: Zamicastat	-	-	-	1件: 86